Hemab Therapeutics Holdings, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | $-115.3M | — |
| Mar 2025 | — | $-129.1M | — |
| Jun 2025 | — | $-141.5M | — |
| Dec 2025 | — | $-176.6M | $88.0M |
| Mar 2026 | — | $-198.6M | $49.9M |
| Jun 2026 | — | $454.3M | $237.4M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | $-115.3M | — |
| Mar 2025 | — | $-129.1M | — |
| Jun 2025 | — | $-141.5M | — |
| Dec 2025 | — | $-176.6M | $88.0M |
| Mar 2026 | — | $-198.6M | $49.9M |
| Jun 2026 | — | $454.3M | $237.4M |